Kruse Bo — SEC Form 4 filings

SEC reporting owner CIK 1752940. 2 Form 4 filings on record with FilingPulse; latest filed 2024-05-31.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2024-01-22 to 2024-05-31. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Y-mAbs Therapeutics, Inc. (YMAB)EVP, CFO, SECRY & TREAS.22 legs · 60,000 sh · $723,0556

Form 4 filings — Kruse Bo

FiledFormIssuerReported transactionsSource
2024-05-314Y-mAbs Therapeutics, Inc. (YMAB)Option exercise (M): 28,629 @ $2 · Sale (S): 28,629 @ $12.03 · Option exercise (M): 31,371 @ $2 · Sale (S): 31,371 @ $12.07 · Option exercise (M): 28,629 (derivative) @ $0 · Option exercise (M): 31,371 (derivative) @ $0EDGAR
2024-01-224Y-mAbs Therapeutics, Inc. (YMAB)Grant/award (A): 18,100 @ $0 · Grant/award (A): 108,900 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1752940 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →